Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Predicting outcomes in native AV forearm radio-cephalic fistulae; the CAVeA2T2 scoring system.

Bosanquet, David C. ORCID: https://orcid.org/0000-0003-2304-0489, Rubasingham, Jeffrey, Imam, Mariam, Woolgar, Justin D. and Davies, Christopher G. 2015. Predicting outcomes in native AV forearm radio-cephalic fistulae; the CAVeA2T2 scoring system. The Journal of Vascular Access 16 (1) , pp. 19-25. 10.5301/jva.5000305

Full text not available from this repository.

Abstract

Purpose The aim of this study was to identify significant factors relating to fistula survival and create an easy-to-use scoring system for predicting fistula patency rates. Methods A total of 276 consecutive radio-cephalic forearm fistulae created in a single tertiary vascular unit were identified retrospectively. Numerous patient- and fistula-related demographics were noted. Cox regression analysis was used to identify significant factors predictive of reduced fistula patency rates, and significant variables weighted according to their hazard ratio. Results Five significant factors were identified: ipsilateral Central venous access, Age >73 years, anastomosed Vein <2.2 mm, previous lower limb Angioplasty and absent intraoperative Thrill (1 point for first three variables, 2 points for the latter two). The CAVeA2T2 score (maximum 7 points) significantly predicted for reduced fistula patency (p = 0.001) and a reduced rate of successful dialysis (p = 0.001). Fistulae with CAVeA2T2 scores ≥2 had 6 week and 1 year patency rates significantly below pooled published rates. Without scoring for thrill, that is in the pre-operative setting, the scoring system remained significant at all stages. Conclusion The CAVeA2T2, scoring system is a potential scoring system for predicting fistula patency rates and the likelihood of dialysing through a fistula. Further studies and/or external validation is required in the context of methodological limitations. How to manage patients with a high CAVeA2T2 score is unknown.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: SAGE Publications
ISSN: 1129-7298
Date of Acceptance: 6 August 2014
Last Modified: 28 Jun 2024 09:30
URI: https://orca.cardiff.ac.uk/id/eprint/169982

Actions (repository staff only)

Edit Item Edit Item